Zymeworks Announces Appointment Of Dr. Alessandra Cesano To Its Board Of Directors
VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, announced the… Read More



